Anxiety and Anxiolytic Drugs [electronic resource] / edited by Florian Holsboer, Andreas Ströhle.

Call Number
615
Title
Anxiety and Anxiolytic Drugs edited by Florian Holsboer, Andreas Ströhle.
Physical Description
XIV, 566 p. online resource.
Series
Handbook of Experimental Pharmacology, 0171-2004 ; 169
Contents
Learning and Memory -- Animal Models of Anxiety -- Genetic Alterations of the Murine Serotonergic Gene Pathway: The Neurodevelopmental Basis of Anxiety -- Mutagenesis and Knockout Models: Hypothalamic-Pituitary-Adrenocortical System -- Mutagenesis and Knockout Models: NK1 and Substance P -- Genetic Epidemiology of Anxiety Disorders -- Interactions Between Corticotropin-Releasing Hormone and Serotonin: Implications for the Aetiology and Treatment of Anxiety Disorders -- Anxiety Disorders: Noradrenergic Neurotransmission -- Pathophysiology and Pharmacology of GABAA Receptors -- Excitatory Amino Acid Neurotransmission -- Neurobiology and Treatment of Anxiety: Signal Transduction and Neural Plasticity -- Neuropeptides in Anxiety Modulation -- Neuroendocrine Aspects of PTSD -- Anxiety Disorders: Clinical Presentation and Epidemiology -- Transcultural Issues -- Challenge Studies in Anxiety Disorders -- Pharmacotherapy of Anxiety -- New Pharmacological Treatment Approaches for Anxiety Disorders -- Pharmacogenomics -- Pharmacoproteomics.
Summary
The present volume gives a comprehensive overview on the current state of basic and clinical research on Anxiety and Anxiolytic Drugs. Using newly developed methods and techniques researchers are now beginning to understand the molecular mechanisms of anxiety, anxiety disorders and their treatment. In parallel, new drug targets have been generated and the first clinical studies with new compounds have been started. In 20 chapters written by numerous experts in the field comprehensive information on all relevant topics is provided.
Added Author
Holsboer, Florian. editor.
Ströhle, Andreas. editor.
SpringerLink (Online service)
Subject
MEDICINE.
NEUROSCIENCES.
PHARMACOLOGY.
PSYCHIATRY.
PSYCHOPHARMACOLOGY.
Biomedicine.
Pharmacology/Toxicology.
Neurosciences.
Psychiatry.
Psychopharmacology.
Multimedia
  • Libraries with this item
Total Ratings: 0
No records found to display.
 
 
 
03330nam a22005415i 4500
001
 
 
vtls001568740
003
 
 
VRT
005
 
 
20170831184700.0
007
 
 
cr nn 008mamaa
008
 
 
170831s2005    gw |    s    |||| 0|eng d
020
$a 9783540280828 $9 978-3-540-28082-8
024
7
$a 10.1007/3-540-28082-0 $2 doi
035
$a (DE-He213)978-3-540-28082-8
039
9
$y 201708311847 $z santha
050
4
$a RM1-950
072
7
$a MMG $2 bicssc
072
7
$a MED071000 $2 bisacsh
082
0
4
$a 615 $2 23
245
1
0
$a Anxiety and Anxiolytic Drugs $h [electronic resource] / $c edited by Florian Holsboer, Andreas Ströhle.
264
1
$a Berlin, Heidelberg : $b Springer Berlin Heidelberg, $c 2005.
300
$a XIV, 566 p. $b online resource.
336
$a text $b txt $2 rdacontent
337
$a computer $b c $2 rdamedia
338
$a online resource $b cr $2 rdacarrier
347
$a text file $b PDF $2 rda
490
1
$a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 169
505
0
$a Learning and Memory -- Animal Models of Anxiety -- Genetic Alterations of the Murine Serotonergic Gene Pathway: The Neurodevelopmental Basis of Anxiety -- Mutagenesis and Knockout Models: Hypothalamic-Pituitary-Adrenocortical System -- Mutagenesis and Knockout Models: NK1 and Substance P -- Genetic Epidemiology of Anxiety Disorders -- Interactions Between Corticotropin-Releasing Hormone and Serotonin: Implications for the Aetiology and Treatment of Anxiety Disorders -- Anxiety Disorders: Noradrenergic Neurotransmission -- Pathophysiology and Pharmacology of GABAA Receptors -- Excitatory Amino Acid Neurotransmission -- Neurobiology and Treatment of Anxiety: Signal Transduction and Neural Plasticity -- Neuropeptides in Anxiety Modulation -- Neuroendocrine Aspects of PTSD -- Anxiety Disorders: Clinical Presentation and Epidemiology -- Transcultural Issues -- Challenge Studies in Anxiety Disorders -- Pharmacotherapy of Anxiety -- New Pharmacological Treatment Approaches for Anxiety Disorders -- Pharmacogenomics -- Pharmacoproteomics.
520
$a The present volume gives a comprehensive overview on the current state of basic and clinical research on Anxiety and Anxiolytic Drugs. Using newly developed methods and techniques researchers are now beginning to understand the molecular mechanisms of anxiety, anxiety disorders and their treatment. In parallel, new drug targets have been generated and the first clinical studies with new compounds have been started. In 20 chapters written by numerous experts in the field comprehensive information on all relevant topics is provided.
650
0
$a MEDICINE.
650
0
$a NEUROSCIENCES.
650
0
$a PHARMACOLOGY.
650
0
$a PSYCHIATRY.
650
0
$a PSYCHOPHARMACOLOGY.
650
1
4
$a Biomedicine.
650
2
4
$a Pharmacology/Toxicology.
650
2
4
$a Neurosciences.
650
2
4
$a Psychiatry.
650
2
4
$a Psychopharmacology.
700
1
$a Holsboer, Florian. $e editor.
700
1
$a Ströhle, Andreas. $e editor.
710
2
$a SpringerLink (Online service)
773
0
$t Springer eBooks
776
0
8
$i Printed edition: $z 9783540225683
830
0
$a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 169
856
4
0
$u http://dx.doi.org/10.1007/3-540-28082-0
912
$a ZDB-2-SBL
950
$a Biomedical and Life Sciences (Springer-11642)
999
$a VIRTUA               
No Reviews to Display
Summary
The present volume gives a comprehensive overview on the current state of basic and clinical research on Anxiety and Anxiolytic Drugs. Using newly developed methods and techniques researchers are now beginning to understand the molecular mechanisms of anxiety, anxiety disorders and their treatment. In parallel, new drug targets have been generated and the first clinical studies with new compounds have been started. In 20 chapters written by numerous experts in the field comprehensive information on all relevant topics is provided.
Contents
Learning and Memory -- Animal Models of Anxiety -- Genetic Alterations of the Murine Serotonergic Gene Pathway: The Neurodevelopmental Basis of Anxiety -- Mutagenesis and Knockout Models: Hypothalamic-Pituitary-Adrenocortical System -- Mutagenesis and Knockout Models: NK1 and Substance P -- Genetic Epidemiology of Anxiety Disorders -- Interactions Between Corticotropin-Releasing Hormone and Serotonin: Implications for the Aetiology and Treatment of Anxiety Disorders -- Anxiety Disorders: Noradrenergic Neurotransmission -- Pathophysiology and Pharmacology of GABAA Receptors -- Excitatory Amino Acid Neurotransmission -- Neurobiology and Treatment of Anxiety: Signal Transduction and Neural Plasticity -- Neuropeptides in Anxiety Modulation -- Neuroendocrine Aspects of PTSD -- Anxiety Disorders: Clinical Presentation and Epidemiology -- Transcultural Issues -- Challenge Studies in Anxiety Disorders -- Pharmacotherapy of Anxiety -- New Pharmacological Treatment Approaches for Anxiety Disorders -- Pharmacogenomics -- Pharmacoproteomics.
Subject
MEDICINE.
NEUROSCIENCES.
PHARMACOLOGY.
PSYCHIATRY.
PSYCHOPHARMACOLOGY.
Biomedicine.
Pharmacology/Toxicology.
Neurosciences.
Psychiatry.
Psychopharmacology.
Multimedia